Additionally, the JAK-STAT pathway was activated as cytoplasmic SOCS3 immunostaining was significantly stronger in NASH than in NAFL (p < 0.001; Figure 2G–I). This evidence concerns the gene SOAT1 and metabolic dysfunction-associated steatohepatitis.